Menu
Menu
Zydus Lifesciences has partnered with Viwit Pharmaceuticals to exclusively market and sell gadobutrol and gadoterate meglumine MRI injectables in the US. This strategic agreement positions Zydus to capitalize on a significant market opportunity, potentially boosting its presence in the global pharmaceutical sector. Learn more about the implications of this partnership for both companies and the MRI contrast agent industry.